Cancer immunotherapy: Macrophages steal the show

Nature Reviews Drug Discovery 16, 455 (2017). doi:10.1038/nrd.2017.126 Author: M. Teresa Villanueva The past decade has seen remarkable advances in tumour immunology due to extensive research on inhibition of programmed cell death protein 1 (PD1) — which is expressed on T cells — and its ligand PDL1, which is expressed on tumour cells. However, little is known
Source: Nature Reviews Drug Discovery - Category: Drugs & Pharmacology Authors: Tags: Research Highlight Source Type: research